Remarks at Conference on Directions in Health Economics Regarding Research on Health Insurance and Biomedical Research and Development.

by Joseph P. Newhouse


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback6 pages $20.00 $16.00 20% Web Discount

Comments on significant research opportunities for economists: (1) Why does health insurance cover minor costs better than major ones--why comparatively low upper limits? (2) What is the effect of methods of reimbursing providers of medical care? (3) Market structure problems. (4) Difficulties in measuring elasticity of demand. (5) Understanding health stock loss. (6) Effects of price schedules. (7) Marginal prices. Turning to R&D, development is defined as improving a product along existing quantifiable dimensions, and research as introducing new products (new dimensions). (8) Has reimbursement insurance reduced development in cost reduction? (9) What is the tradeoff between expenditure and speed of development? (10) What is optimal patent policy? (11) Optimal size and distribution of research firms and researchers? (12) Incentives for efficiency? (13) Optimal length of support--what is the tradeoff between the greater responsiveness and control obtained with shorter periods, vs. greater insecurity and nonproductive times writing proposals? 6 pp. Ref.

This report is part of the RAND Corporation Paper series. The paper was a product of the RAND Corporation from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.